Isolates Currently Available
Isolates as of May 28, 2018
Organism | Year (number of unique strains) | Demographic and clinical data available | Laboratory testing results available |
---|---|---|---|
Streptococcus pneumoniae | 1995 (n=647) 1996 (n=492) 1997 (n=640) 1998 (n=3168) 1999 (n=3979) 2000 (n=3736) 2001 (n=3529) 2002 (n=3147) 2003 (n=3242) 2004 (n=3067) 2005 (n=3489) 2006 (n=3530) 2007 (n=3534) 2008 (n=3775) 2009 (n=3863) 2010 (n=3608) 2011 (n=3300) 2012 (n=2869) 2013 (n=3015) 2014 (n=2388) 2015 (n=2339) 2016 (n=2757) 2017 (n=2951) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Source: cerebrospinal fluid (CSF), blood, or other sterile site |
Serotype
Minimum inhibitory concentration for select antibiotics |
Group A Streptococcus | 1995 (n=278) 1996 (n=135) 1997 (n=206) 1998 (n=525) 1999 (n=653) 2000 (n=538) 2001 (n=326) 2002 (n=794) 2003 (n=1109) 2004 (n=856) 2005 (n=901) 2006 (n=982) 2007 (n=968) 2008 (n=962) 2009 (n=966) 2010 (n=1039) 2011 (n=1117) 2012 (n=908) 2013 (n=1029) 2014 (n=1270) 2015 (n=1399) 2016 (n=1745) 2017 (n=2218) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Presence or absence of the following severe infections: NF*, STSS**, puerperal sepsis Source: CSF, blood, or other sterile site |
emm typePresence or absence of serum opacity factor |
Group B Streptococcus | 1995 (n=4) 1996 (n=1) 1997 (n=0) 1998 (n=301) 1999 (n=372) 2000 (n=319) 2001 (n=261) 2002 (n=635) 2003 (n=1172) 2004 (n=1316) 2005 (n=1455) 2006 (n=1302) 2007 (n=1216) 2008 (n=1286) 2009 (n=1426) 2010 (n=1474) 2011 (n=1757) 2012 (n=1905) 2013 (n=2015) 2014 (n=1983) 2015 (n=2105) 2016 (n=2199) 2017 (n=2317) |
Data varies by age group.
For <1 year olds: onset [early (“0-6 days”), late (“7-89 days”) or other (≥90 days)] For 1-49 year olds: pregnant (yes, no, unknown) For 50-64 and ≥ 65 year olds: age group only Source: CSF, blood, or other sterile site |
Serotype |
Methicillin-Resistant Staphylococcus aureus | The ABCs program no longer manages MRSA isolates. Find more information about MRSA surveillance. | ||
H. influenzae | 1995(n=0) 1996(n=5) 1997(n=10) 1998(n= 242) 1999(n=248) 2000(n=306) 2001(n= 376) 2002(n=389) 2003(n=393) 2004(n=418) 2005(n=404) 2006(n=488) 2007(n=459) 2008(n=487) 2009(n=526) 2010(n=540) 2011(n=595) 2012(n= 606) 2013(n=674) 2014(n=639) 2015(n=728) 2016(n=767) 2017(n=921) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Source: CSF, blood, or other sterile site |
Serotype |
N. meningitidis | 1995(n=150) 1996(n=253) 1997(n=291) 1998(n= 259) 1999(n=302) 2000(n=237) 2001(n= 254) 2002(n=180) 2003(n=195) 2004(n=140) 2005(n=156) 2006(n=138) 2007(n=145) 2008(n=148) 2009(n=122) 2010(n=76) 2011(n=94) 2012(n= 72) 2013(n=51) 2014(n=58) 2015(n=66) 2016(n=61) 2017(n=53) |
Age groups: < 1 yr, 1 yr, 2-4 yrs, 5-17 yrs, 18-34 yrs, 35-49 yrs, 50-64 yrs, ≥ 65 yrs
Source: CSF, blood, or other sterile site |
Serogroup |
*Necrotizing fasciitis
** Streptococcal toxic shock syndrome
† Panton-Valentine leukocidin
§ Toxic shock syndrome toxin
Page last reviewed: June 4, 2020